More Exposure

NASDAQ today will add six biotech companies to its NASDAQ-100 index as part of its annual re-ranking of the index. Biotech companies represent nearly half of the 13 new entrants. The move means more biotech exposure in the bellwether index, which consists of the 100 largest non-financial companies listed on the exchange. Perhaps more importantly, it also means a